| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $742.0M | +1.9% | +11.6% |
| Cost of Revenue | $170.0M | +1.2% | +8.3% |
| Gross Profit | $572.0M | +2.1% | +12.6% |
| R&D Expense | $160.0M | +0.0% | +1.3% |
| SG&A Expense | $118.0M | +4.4% | +7.3% |
| Operating Income | $23.0M | -43.9% | +243.8% |
| Pre-tax Income | $50.0M | -25.4% | +100.0% |
| Income Tax | $7.0M | — | -22.2% |
| Net Income | $43.0M | -35.8% | +168.8% |
| EPS (Basic) | $0.24 | -36.8% | +166.7% |
| EPS (Diluted) | $0.24 | -35.1% | — |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $645.0M | -26.4% | +108.1% |
| Short-term Investments | $1.82B | -8.3% | -6.2% |
| Accounts Receivable | $463.0M | +11.0% | +0.0% |
| Current Assets | $3.20B | -10.2% | +6.6% |
| Total Assets | $9.23B | -3.4% | +2.4% |
| Current Liabilities | $2.18B |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $626.0M | — | — |
| Capital Expenditures | $7.0M | — | — |
| Investing Cash Flow | $223.0M | — | — |
| Financing Cash Flow | -$622.0M | — | — |
| Free Cash Flow | $619.0M | — | — |
| -2.2% |
| Total Liabilities | $2.34B | -16.5% | -14.9% |
| Stockholders' Equity | $6.89B | +2.1% | +10.0% |